December 04, 2025

FDA Approves Biologic for Nerve Repair

A newly licensed biologic offers a novel approach to repairing complex peripheral nerve injuries across pediatric and adult populations.

Conexiant

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

December 03, 2025

Are New Incentives Boosting Births?

A report on recent federal pronatalist policy initiatives, proposed IVF access measures, and associated government actions involving women’s and children’s health programs in the US.

KFF Health News

December 03, 2025

Sandoz Launches Aflibercept Biosimilar in Europe

New treatment option for patients with retinal diseases

The Ophthalmologist

December 02, 2025

FDA Clears Rapid Bordetella PCR Test

The assay detects and differentiates key Bordetella species at the point of care, providing rapid results that support timely pertussis evaluation.

Conexiant

December 02, 2025

Corticosteroids Cut Mortality in Severe Pneumonia

Meta-analysis of 20 trials finds 27% reduction in short-term deaths, no increase in infections

Conexiant

November 27, 2025

Researchers Unveil Multiplex PCR for Endemic Fungi

At AMP 2025, scientists from Indiana University presented data on a rapid, highly specific PCR assay for histoplasmosis, blastomycosis, and coccidioidomycosis.

The Pathologist

November 26, 2025

FDA Grants Accelerated Approval of Voyxact

The subcutaneous injection offers a new option for adults at risk of progression to kidney failure.

Conexiant

November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant